TOP STORIES

• ORGANIZATION 4-Ministers’ Pact Has Effectively Been Scrapped with 2025 Off-Year Revision Plan: FPMAJ Chair
  January 7, 2025

• ORGANIZATION As 2025 Begins, Industry Leaders Renew Resolve towards Next Reforms
  January 6, 2025

• REGULATORY Japan Approves Zepbound, Qalsody, and Lots More Drugs
  December 27, 2024

• REGULATORY Quality Assurance and Lag/Loss Fight to Form Pillars of PMD Act Amendment
  December 27, 2024

• REGULATORY Chuikyo OKs Outline of FY2025 Off-Year Drug Price Revision
  December 26, 2024

• TRENDS Top 10 PHARMA JAPAN Articles of 2024
  December 25, 2024

• REGULATORY Deferred PMP Cuts Likely to Batter Stelara; 7 Drugs Subject to Rule after LOE
  December 24, 2024

• REGULATORY CEA Expansion, Higher Copay Likely to Be Included in Minister Budget Deal
  December 24, 2024

• COMMENTARY Where Do Japan Drug Makers Stand? A Comparison with Other Industries and Mega Pharma Peers
  December 24, 2024

• REGULATORY Off-Year Price Revision to Hit 53% of Listed Drugs in 2025, Down from 69%
  December 23, 2024

• REGULATORY Three Ministers Agree on Off-Year Drug Price Revision in FY2025
  December 20, 2024

• REGULATORY Japan Set to Settle Off-Year Debate with “x1.0” Threshold for PMP Meds/Generics, “x0.5” for LLPs
  December 20, 2024

• REGULATORY Japan Weighs Tweaking “x0.625” Threshold to Narrow Off-Year Revision Coverage
  December 19, 2024

• REGULATORY Japan to Add Shingles Vaccines to NIP List from FY2025, Targeting Age 65
  December 19, 2024

• ORGANIZATION JPA Calls for Improving Package Units as Pharmacies Suffer with Unsold Stocks of Pricey Meds
  December 19, 2024

• BUSINESS Jazz’s Epilepsy Drug Candidate Nearing Submission as Japan Lifts Ban on Cannabis-Derived Meds
  December 18, 2024

• REGULATORY Ruling Bloc’s Draft Budget Policy Says Off-Year Revisions Could Alter, but DPP Calls for Explicit Mention of Repeal
  December 17, 2024

• BUSINESS Takeda Sees Up to US$20 Billion Sales Potential with 6 Late-Stage Assets
  December 16, 2024

• BUSINESS Amgen Japan Marks “Significant Milestone” with Tepezza Release, Eyes More Launches
  December 16, 2024

• REGULATORY LDP’s Tamura Renews Question over Product Coverage of Off-Year Revisions
  December 16, 2024

ページ

• « 先頭
• ‹ Prev
• …
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• …
• Next ›
• 最終 »